Triglycerides potentiate the inflammatory response in rat Kupffer cells

Antioxidants and Redox Signaling

Volumn 10, Issue 12, 2008, Pages 2009-2022

  Budick Harmelin, Noga ^a   Dudas, Jozsef ^b   Demuth, Julia ^b   Madar, Zecharia ^a   Ramadori, Giuliano ^b   Tirosh, Oren ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; INFLAMMATION; KUPFFER CELL; MALE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIGENS, CD14; BLOTTING, WESTERN; CELLS, CULTURED; CYTOKINES; DRUG SYNERGISM; GENE EXPRESSION; GLUTATHIONE; KUPFFER CELLS; LIPOPOLYSACCHARIDES; MALE; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRILES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFONES; TOLL-LIKE RECEPTOR 4; TRIGLYCERIDES; ZYMOSAN;

RATTUS;

EID: 52949153548     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1876     Document Type: Article

References (53)

1. Aharoni-Simon M, Reifen R, and Tirosh O. ROS-production-mediated activation of AP-1 but not NFkappaB inhibits glutamate-induced HT4 neuronal cell death. Antioxid Redox Signal 8: 1339-1349, 2006.
2. Armbrust T and Ramadori G. Functional characterization of two different Kupffer cell populations of normal rat liver. J Hepatol 25: 518-528, 1996.
3. Armbrust T, Schwogler S, Zohrens G, and Ramadori G. C1 esterase inhibitor gene expression in rat Kupffer cells, peritoneal macrophages and blood monocytes: modulation by interferon gamma. J Exp Med 178: 373-380, 1993.
4. Aronis A, Madar Z, and Tirosh O. Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Radic Biol Med 38: 1221-1230, 2005.
5. Bilzer M, Roggel F, and Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 26: 1175-1186, 2006.
6. Blackwell TS and Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 17: 3-9, 1997.
7. Browning JD and Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114: 147-152, 2004.
8. Calder PC, Bond JA, Harvey DJ, Gordon S, and Newsholme EA. Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J 269: 807-814, 1990.
9. Canbay A, Bechmann L, and Gerken G. Lipid metabolism in the liver. Z Gastroenterol 45: 35-41, 2007.
10. Carvalho MD, Harada LM, Gidlund M, Ketelhuth DF, Boschcov P, and Quintao EC. Macrophages take up triacylglycerol-rich emulsions at a faster rate upon co-incubation with native and modified LDL: an investigation on the role of natural chylomicrons in atherosclerosis. J Cell Biochem 84: 309-323, 2002.
11. Ceppi ED, Smith FS, and Titheradge MA. Effect of multiple cytokines plus bacterial endotoxin on glucose and nitric oxide production by cultured hepatocytes. Biochem J 317: 503-507, 1996.
12. Chaet MS, Garcia VF, Arya G, and Ziegler MM. Dietary fish oil enhances macrophage production of nitric oxide. J Surg Res 57: 65-68, 1994.
13. Chakravortty D and Hensel M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect 5: 621-627, 2003.
14. Cirino G, Fiorucci S, and Sessa WC. Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol Sci 24: 91-95, 2003.
15. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, and Pons-Romero F. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34: 1158-1163, 2001.
16. de Lima TM, de Sa Lima L, Scavone C, and Curi R. Fatty acid control of nitric oxide production by macrophages. FEBS Lett 580: 3287-3295, 2006.
17. Ding WX and Yin XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med 8: 445-454, 2004.
18. Feder LS and Laskin DL. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia. J Leukoc Biol 55: 507-513, 1994.
19. Ferre N and Claria J. New insights into the regulation of liver inflammation and oxidative stress. Mini Rev Med Chem 6: 1321-1330, 2006.
20. Fowler SD and Greenspan P. Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: comparison with oil red O. J Histochem Cytochem 33: 833-836, 1985.
21. Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, Simmons RL, and Billiar TR. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A 90: 522-526, 1993.
22. Guglielmi FW, Boggio-Bertinet D, Federico A, Forte GB, Guglielmi A, Loguercio C, Mazzuoli S, Merli M, Palmo A, Panella C, Pironi L, and Francavilla A. Total parenteral nutrition-related gastroenterological complications. Dig Liver Dis 38: 623-642, 2006.
23. Hareng L and Hartung T. Induction and regulation of endogenous granulocyte colony-stimulating factor formation. Biol Chem 383: 1501-1517, 2002.
24. Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M, and Kikugawa K. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22: 3356-3366, 2003.
25. Hill MR, Kelly K, Wu X, Wanker F, Bass H, Morgan C, Wang C, and Gimble JM. Lipopolysaccharide regulation of lipoprotein lipase expression in murine macrophages. Infect Immun 63: 858-864, 1995.
26. Jaeschke H. Mechanisms of liver injury, II: Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 290: G1083-G1088, 2006.
27. Janssen YM and Sen CK. Nuclear factor kappa B activity in response to oxidants and antioxidants. Methods Enzymol 300: 363-374, 1999.
28. Kitade H, Sakitani K, Inoue K, Masu Y, Kawada N, Hiramatsu Y, Kamiyama Y, Okumura T, and Ito S. Interleukin 1 beta markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Hepatology 23: 797-802, 1996.
29. Knook DL and Sleyster EC. Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp Cell Res 99: 444-449, 1976.
30. Laskin JD, Heck DE, Gardner CR, and Laskin DL. Prooxidant and antioxidant functions of nitric oxide in liver toxicity. Antioxid Redox Signal 3: 261-271, 2001.
31. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, and Diehl AM. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37: 343-350, 2003.
32. Loguercio C, De Simone T, Federico A, Terracciano F, Tuccillo C, Di Chicco M, and Carteni M. Gut-liver axis: a new point of attack to treat chronic liver damage? Am J Gastroenterol 97: 2144-2146, 2002.
33. Matsuura K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, and Yamamoto S. Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J Exp Med 179: 1671-1676, 1994.
34. Nolan JP and Vilayat M. Endotoxin and the liver, I: Toxicity in rats with choline deficient fatty livers. Proc Soc Exp Biol Med 129: 29-31, 1968.
35. Oshita M, Takehara H, Yamaguchi M, Doi K, Ueda N, Naito S, Hiraoka I, and Tashiro S. Significance of administration of fat emulsion: hepatic changes in infant rats receiving total parenteral nutrition with and without fat. Clin Nutr 23: 1060-1068, 2004.
36. Pajkrt D, Manten A, van der Poll T, Tiel-van Buul MM, Jansen J, Wouter ten Cate J, and van Deventer SJ. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 90: 1415-1424, 1997.
37. Pappo I, Bercovier H, Berry EM, Haviv Y, Gallily R, and Freund HR. Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide. J Parenter Enteral Nutr 16: 529-532, 1992.
38. Ramadori G and Saile B. Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology 127: 997- 1000, 2004.
39. Rensen PC, Oosten M, Bilt E, Eck M, Kuiper J, and Berkel TJ. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest 99: 2438-2445, 1997.
40. Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, and Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of nonalcoholic steatohepatitis. J Hepatol 47: 571-579, 2007.
41. Rockey DC and Chung JJ. Regulation of inducible nitric oxide synthase in hepatic sinusoidal endothelial cells. Am J Physiol 271: G260-G267, 1996.
42. Satapathy SK, Sakhuja P, Malhotra V, Sharma BC, and Sarin SK. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 22: 634-638, 2007.
43. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14: 281-287, 2003.
44. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, and Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015-3025, 2006.
45. Solga SF and Diehl AM. Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J Hepatol 38: 681-687, 2003.
46. Spolarics Z and Wu JX. Role of glutathione and catalase in H2O2 detoxification in LPS-activated hepatic endothelial and Kupffer cells. Am J Physiol 273: G1304-G1311, 1997.
47. Stuehr DJ, Kwon NS, and Nathan CF. FAD and GSH participate in macrophage synthesis of nitric oxide. Biochem Biophys Res Commun 168: 558-565, 1990.
48. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283: G256-G265, 2002.
49. Tilg H and Hotamisligil GS. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131: 934-945, 2006.
50. Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, Han JY, Kato S, Shimoda M, Oike Y, Tomizawa M, Makino S, Ohkura T, Saito H, Kumagai N, Nagata H, Ishii H, and Hibi T. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55: 415-424, 2006.
51. Wetzler LM. The role of Toll-like receptor 2 in microbial disease and immunity. Vaccine 21(suppl 2): S55-S60, 2003.
52. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, and Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48: 206-211, 2001.
53. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, and Diehl AM. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45: 1366-1374, 2007.